|
Cancer and Leukemia Group B
|
5U10CA031946-26
|
$10,080,981
|
$705,669
|
SCHILSKY, RICHARD
|
UNIVERSITY OF CHICAGO
|
|
Cancer and Leukemia Group B Statistical Center
|
5U10CA033601-28
|
$5,064,881
|
$354,542
|
GEORGE, STEPHEN
|
DUKE UNIVERSITY
|
|
Chronic Lymphocytic Leukemia Research Consortium
|
5P01CA081534-08
|
$3,827,483
|
$765,497
|
KIPPS, THOMAS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Emory-GA Tech Nanotechnology Center for Personalized an*
|
5U54CA119338-03
|
$3,565,272
|
$178,264
|
NIE, SHUMING
|
EMORY UNIVERSITY
|
|
THERAPY OF CML
|
5P01CA049639-19
|
$3,552,240
|
$710,448
|
CHAMPLIN, RICHARD
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Carolina Center of Cancer Nanotechnology Excellence
|
5U54CA119343-03
|
$3,373,755
|
$168,688
|
JULIANO, RUDOLPH
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
Bone Marrow Transplantation in Human Disease
|
2P01CA015396-32A1
|
$2,857,642
|
$285,764
|
JONES, RICHARD
|
JOHNS HOPKINS UNIVERSITY
|
|
Hematopoietic Cell Transplantation for Hematologic Malignancies
|
5P01CA030206-25
|
$2,776,839
|
$555,368
|
FORMAN, STEPHEN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
SPORE in Prostate Cancer
|
5P50CA092629-07
|
$2,640,179
|
$1,320,090
|
SCARDINO, PETER
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Targeting Vessels in Tumors
|
5P01CA104898-03
|
$2,615,782
|
$261,578
|
SCHNITZER, JAN
|
SIDNEY KIMMEL CANCER CENTER
|
|
SPORE in Genitourinary Cancer
|
5P50CA091846-07
|
$2,549,962
|
$509,992
|
DINNEY, COLIN
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
SPORE IN PROSTATE CANCER
|
5P50CA058236-13
|
$2,532,522
|
$506,504
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Radiologial Physics Center
|
5U10CA010953-39
|
$2,431,121
|
$24,311
|
IBBOTT, GEOFFREY
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
THE THERAPY OF AML
|
2P01CA055164-15A1
|
$2,404,845
|
$120,242
|
ANDREEFF, MICHAEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
SPORE in Breast Cancer
|
5P50CA058207-13
|
$2,359,341
|
$471,868
|
GRAY, JOE
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
SPORE in Lung Cancer
|
5P50CA070907-10
|
$2,353,640
|
$470,728
|
MINNA, JOHN
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
|
SPORE in Prostate Cancer
|
5P50CA091956-07
|
$2,277,704
|
$911,082
|
TINDALL, DONALD
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
|
BRAIN TUMOR SPORE GRANT
|
2P50CA097257-06
|
$2,252,869
|
$112,643
|
BERGER, MITCHEL
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
University of Texas MD Anderson SPORE in Ovarian Cancer
|
5P50CA083639-08
|
$2,249,522
|
$899,809
|
BAST, ROBERT
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Neuroblastoma Biology and Therapy
|
5P01CA097323-05
|
$2,216,467
|
$221,647
|
BRODEUR, GARRETT
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
Pacific Ovarian Cancer Research Consoritum
|
5P50CA083636-09
|
$2,191,597
|
$547,899
|
URBAN, NICOLE
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
UTMDACC SPORE in Breast Cancer
|
5P50CA116199-03
|
$2,180,817
|
$545,204
|
HORTOBAGYI, GABRIEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
City of Hope Lymphoma SPORE
|
5P50CA107399-04
|
$2,163,323
|
$540,831
|
FORMAN, STEPHEN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Biology & Transplantation of the Human Stem Cell
|
5P01CA065493-13
|
$2,065,942
|
$1,549,457
|
MCGLAVE, PHILIP
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
|
Epithelial Ovarian Cancer Program Project
|
5P01CA052477-15
|
$2,029,433
|
$202,943
|
SPRIGGS, DAVID
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Genetic Approaches to Cancer Immunotherapy
|
5P01CA059350-14
|
$1,984,035
|
$1,091,219
|
SADELAIN, MICHEL
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Motility and Invasion
|
5P01CA100324-05
|
$1,943,844
|
$194,384
|
CONDEELIS, JOHN
|
YESHIVA UNIVERSITY
|
|
Center for Molecular Imaging Research at MGH/HMS
|
5P50CA086355-08
|
$1,942,000
|
$485,500
|
WEISSLEDER, RALPH
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
MSKCC Center for Molecular Imaging in Cancer
|
5P50CA086438-07
|
$1,941,997
|
$194,200
|
Blasberg, Ronald
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
JHU ICMIC PROGRAM
|
5P50CA103175-05
|
$1,896,362
|
$379,272
|
Bhujwalla, Zaver
|
JOHNS HOPKINS UNIVERSITY
|
|
The UCLA Center for In Vivo Imaging in Cancer Biology
|
5P50CA086306-08
|
$1,891,032
|
$472,758
|
HERSCHMAN, HARVEY
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Quality Assurance Review Center
|
2U10CA029511-28
|
$1,871,106
|
$18,711
|
FITZGERALD, THOMAS
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
Tumor Hypoxia Imaging - Laboratory and Clinical Studies
|
5P01CA115675-02
|
$1,870,179
|
$467,545
|
LING, CLIFTON
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Southeast Cancer Control Consortium, Inc
|
5U10CA045808-21
|
$1,860,642
|
$18,606
|
ATKINS, JAMES
|
SOUTHEAST CANCER CONTROL CONSORTIUM
|
|
Immunotherapy with High Frequency, CEA Specific T Cells
|
5P01CA078673-08
|
$1,766,526
|
$1,766,526
|
LYERLY, HERBERT
|
DUKE UNIVERSITY
|
|
Clinical and Laboratory Studies of Malignant Lymphomas
|
5P01CA034233-23
|
$1,662,201
|
$332,440
|
LEVY, RONALD
|
STANFORD UNIVERSITY
|
|
Cancer and Leukemia Group B
|
5U10CA037447-24
|
$1,615,920
|
$64,637
|
SCHILSKY, RICHARD
|
UNIVERSITY OF CHICAGO
|
|
INTERACTING FACTORS IN HEMATOPOIESIS AND LEUKEMIA
|
5P01CA072009-10
|
$1,583,949
|
$316,790
|
TENEN, DANIEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
CD8+ T Cells and Immunological Tumor Regression
|
5P01CA097296-05
|
$1,514,024
|
$227,104
|
Schreiber, Hans
|
UNIVERSITY OF CHICAGO
|
|
Extension of Radiotherapy Research
|
5P01CA006294-43
|
$1,506,020
|
$1,506,020
|
ANG, K
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Molecular Basis of Viral and Cellular Transformation
|
5P01CA016038-34
|
$1,463,913
|
$146,391
|
DIMAIO, DANIEL
|
YALE UNIVERSITY
|
|
Mechanisms for Chemoprevention of Cancer
|
5P01CA077839-09
|
$1,374,804
|
$274,961
|
DUBOIS, RAYMOND
|
VANDERBILT UNIVERSITY
|
|
Gene Therapy for Brain Tumors
|
5P01CA069246-11
|
$1,357,853
|
$1,357,853
|
HOCHBERG, FRED
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Molecular Gene and Radiation Therapies for Cancer
|
5P01CA097012-04
|
$1,347,203
|
$1,347,203
|
FREYTAG, SVEND
|
HENRY FORD HEALTH SYSTEM
|
|
Dendritic Cell Biology and Therapy
|
5P01CA073743-09
|
$1,337,018
|
$267,404
|
FINN, OLIVERA
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
PRECLINICAL IN VITRO AND IN VIVO SCREENING ASSAYS FOR CANCER PREVENTIVE AGENT DEV
|
N01CN433002-004
|
$1,326,000
|
$132,600
|
LIPKIN, MARTIN
|
PREVENTIVE MEDICINE INSTITUTE
|
|
Combinatorial Chemistry and Cancer Target
|
5P01CA078045-09
|
$1,316,611
|
$394,983
|
VOGT, PETER
|
SCRIPPS RESEARCH INSTITUTE
|
|
Engineered HSV for Treatment of Malignant Gliomas
|
5P01CA071933-10
|
$1,284,905
|
$1,284,905
|
Whitley, Richard
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Translational Applications of mda-7/IL-24 in Cancer
|
5P01CA104177-03
|
$1,235,688
|
$617,844
|
FISHER, PAUL
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Prostate Cancer: Transition to Androgen-Independence
|
5P01CA077739-08
|
$1,221,220
|
$305,305
|
FRENCH, FRANK
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
Total relevant funding to Gene Therapy for this search: $86,063,332
|